Management of urinary tract infections: A comprehensive review

Pharmacy World and Science

Volumn 19, Issue 5, 1997, Pages 236-245

  Grau, Santiago ^a   Monterde, Josep ^a   Drobnic, Ludvik ^a   Salvadó, Margarita ^b  

^a Hospital Universitari del Mar   (Spain)

^b Laboratori Referencia de Catalunya   (Spain)

Author keywords

Pharmacotherapeutic alternatives; Review; Urinary tract infections

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; AZTREONAM; BETA LACTAM ANTIBIOTIC; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; COTRIMOXAZOLE; ENOXACIN; FOSFOMYCIN; FOSFOMYCIN TROMETAMOL; NITROFURANTOIN; NORFLOXACIN; OFLOXACIN; PIPEMIDIC ACID; QUINOLONE DERIVATIVE; VANCOMYCIN;

ADULT; ANTIMICROBIAL ACTIVITY; CHILD; CYSTITIS; DEFENSE MECHANISM; DISEASE CLASSIFICATION; DRUG CHOICE; FEMALE; HIGH RISK POPULATION; HUMAN; MALE; PYELONEPHRITIS; REVIEW; RISK FACTOR; URINARY TRACT INFECTION;

AGE FACTORS; ANTI-INFECTIVE AGENTS, URINARY; CATHETERIZATION; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; RISK FACTORS; SEX FACTORS; URINARY TRACT INFECTIONS;

EID: 0030822475     PISSN: 09281231     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008600929644     Document Type: Review

References (82)

1. Stamm WE. Nosocomial urinary tract infections. In: Bennett JV, Brachman PS, eds. Hospital Infections. Boston: Little, Brown and Company, 1992: 597-610.
2. Vaqué J, ed. Revalencia de las infecciones nosocomiales en los hospitales españoles: EPINE 1990-1994. Barcelona: Sociedad Española de Higiene y Medicina Preventiva Hospitalarias, 1995.
3. Hatton J, Hughes M, Raymond CH. Management of bacterial urinary tract infections in adults. Ann Pharmacother 1994;28: 1264-72.
4. Hooton TM, Stamm WE. Management of acute uncomplicated urinary tract infection in adults. Med Clin North Am 1991;75: 339-57.
5. Ward TT, Jones SR. Infecciones del tracto genitourinario. In: Reese RE, Betts RF, eds. Un planteamiento practico de las enfermedades infecciosas. Jarpyo editores, Madrid, 1191: 393-427.
6. Nicolle LE, Herding GKM, Preiksaitis J. The association of urinary tract infection with sexual intercourse. J Infect Dis 1982; 146: 579-82.
7. Storm BL, Collins M, West SL. Sexual activity, contraceptive use, and other risk factors for symptomatic and asyptomatic bacteriuria. A case control study. Ann Intern Med 1987;107: 816-20.
8. Raz R, Stamm WE. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. N Engl J Med 1993;329: 753-6.
9. Nicolle LE, Bjornson J, Harding GKM et al. Bacteriuria in elderly institutionalized men. N Engl J Med 1983;309:1420-5.
10. Yoshikawa TT. Chronic urinary tract infections in elderly patients. Hosp Prac 1993;28: 103-18.
11. Nicolle LE. Urinary tract infection in the elderly: how to treat and when? Infection 1992;20(suppl 4): S261-S265.
12. Nicolle LE. Urinary tract infection in the elderly. J Antimicrob Chemother 1994;33(suppl A): 99-109.
13. Haley RW, Gaynes RP, Aber RC, Bennett JV. Surveillance of nosocomial infections. In: Bennett JV, Brachman PS, editors. Hospital Infections. Boston: Little, Brown and Company, 1992: 79-108.
14. Johnson JR, Stamm WE. Urinary tract infections in women: diagnosis and treatment. Ann Intern Med 1989;111: 906-17.
15. Neu HC. Optimal characteristics of agents to treat uncomplicated urinary tract infections. Infections 1992;20(suppl 4) S266-S271.
16. Svanborg-Eden C, Eriksson B, Hanson LA. Adhesion of Escherichia coli to human uroepitelial cells in vitro. Infect Immun 1977;18: 767-74.
17. Stamm WE, Hooton TM. Management of urinary tract infections in adults. N Engl J Med 1993;329: 1328-34.
18. Del Rio G, Dalet F. Ciprofloxacino en las infecciones urinarias en la practica ambulatoria. In: Foz A, Roy C, eds. Medicine. Patologia infecciosa básica. Madrid: IDEPSA, 1989: 329-34.
19. Turnidge J. Principles of appropiate prescribing of antimicrobials. Australian Journal of Hospital Pharmacy. 1995;25: 202-6.
20. Kass EH. 1956. Asymptomatic infections of the urinary tract. Trans. Assoc. Phys. 69: 56-64.
21. Kass EH. 1957. Bacteriuria and the diagnosis of infections of the urinary tract. Arch. Inter. Med. 100: 709-14.
22. Stamm WE, Counts GW, Running KR, Fihn S, Turck M, Holmes KK. Diagnosis of coliform infection in acutely dysuric women. N Engl J Med 1982;307: 463-8.
23. Del Rio G. Tratamiento de las infecciones urinarias. In: Drobnic L, ed. Tratamiento antimicrobiano. Barcelona: Doyma, 1993: 359-66.
24. Gómez J, Pérez M, Hernández JL, Herrero F, Brotons ML, Baños V et al. Bases del uso de antibióticos en las infecciones urinarias. Farmacoterapia 1993;10: 78-86.
25. Pfau A, Sacks TG. Effective postcoital quinolone prophylaxis of recurrent urinary tract infections in women. J Urol 1994;152: 136-8.
26. Saginur R, Nicolle LE. Single-dose compared with 3-day norfloxacine treatment of uncomplicated urinary tract infection in women. Arch Intern Med, 1992;152: 1233-7. 27.
27. Arnal J. Infección urinaria. In: Romero R, Caralps A, eds. Barcelona: Doyma, 1985: 1-38.
28. Del Rio G, Dalet F. Infecciones urinarias II. Tratamiento y profilaxis. Bol Inf Com 1991;1: 72-9.
29. Rodriguez JC, Ruiz M, Elía M, Royo G. Sensibilidad de los patógenos aislados de infecciones urinarias. Rev Esp Quimioterap 1995;8: 73-4.
30. Ronald AR. Urethritis and cystitis. In: Hoeprich PD, Jordan MC, Ronald AR, eds. Infectious diseases. Philadelphia: JB Lippincott Company, 1994: 564-70.
31. Thomson KS, Sanders E, Sanders CC. USA resistance patterns among UTI pathogens. J Antimicrob Chemother 1994; 33(suppl A): 9-15.
32. Grüneberg RN. Changes in urinary pathogens and their antibiotic sensitivities. J. Antimicrob Chemother 1994;33 (suppl A): 1-8.
33. Mensa J, Gatell JM, Jménez de Anta MT, Prats G, Corachán M, Escofet MC, et al. eds. Guía de Terapéutica Antimicrobiana. Barcelona: Massson S.A. 1996.
34. Drobnic L, Grau S, Salas E, Del Villar A, Monterde J, Martínez-Roig A, eds. Guía de Terapéutica Antimicrobiana del Hospital del Mar. Barcelona: IMAS. Hospital del Mar, 1995.
35. Cherney CL, Kaye D. Bacteriuria and pyelonephritis. In: Kass EH, Platt R, eds. Current therapy in infectious disease. Philadelphia: BC Decker Inc, 1990: 190-4.
36. Sanford JP, Gilbert DN, Sande MA, eds. Guide to Antimicrobial Therapy. Dallas: Antimicrobial Therapy Inc., 1996.
37. Sobel JD, Kaye D. Urinary tract infections. In: Mandel GL, Bennett JE, Dolin R, eds. Principles and practice of infectious diseases. New York: Churchill Livingstone Inc, 1995: 662-90.
38. Bailey RR. Cost-benefit consideration in the management of uncomplicated urinary tract infections in sexually active women. N Z Med J 1987;100: 680-3.
39. Norrby SR. Short-term treatment of uncomplicated lower urinary tract infections in women. Rev Infect Dis 1990;12: 458-67.
40. Kunin CM. Urinary Tract Infections in Females. Clin Infect Dis 1994;18: 1-12.
41. Masterton RG, Bochsler JA. High-dosage co-amoxiclav in a single dose versus 7 days of co-trimoxazole as treatment of uncomplicated lower urinary tract infection in women. J Antimicrob Chemother 1995;35: 129-37.
42. Ronald AR, Nicolle LE, Harding GKM. Standards of therapy for urinary tract infections in adults. Infection 1992;20(Suppl 3): S164-S170.
43. Rubin RH, Shapiro ED, Andriole VT, et al. Evaluation of new anti-infective drugs for the treatment of urinary tract infection. Clin Infect Dis 1992;15(Suppl 1): S216-S227.
44. Phisicians' Desk Reference. Medical Economics. 1995: 2356.
45. The Medical Letter: Choice of Cephalosporins. New Rochelle: The Medical Letter Inc 1990;32: 107-10.
46. Neu HC. Fosfomycin-Trometamol: Management of Lower Urinary Tract Infections. Chemother. 1990;36(suppl 1): 53-5.
47. Gómez J, Hernández JL. Fosfomicina y polimixinas. In: Drobnic L, ed. Tratamiento antimicrobiano. Barcelona: Doyma SA, 1993: 201-9.
48. Leibovici L, Greenshtain S, Cohen O et al. Toward improved empiric management of moderate to severe urinary tract infections. Arch Intern Med 1992;152: 2481-6.
49. Shea DJ. Pyelonephritis and female urinary tract infection. Emerg Med Clin North Am 1988;6: 403-17.
50. Neu HC. Microbiologic Aspects of Fluoroquinolones. Am J Ophtalmol 1991;112: 15S-24S.
51. Volaard EJ, Clasener HAL, van Saene HKF, Muller NF. Effect on colonization resistance: an important criterion in selecting antibiotics. DICP 1990;24: 60-6.
52. Diakos GL, Kathpalia SB, Sharifi R, Lolans VT, Jackson GG. Comparison of ciprofloxacin and beta-lactam antibiotics in the treatment of urinary tract infections and alteration of fecal flora. Am J of Med 1987;82(Suppl 4A): 290-4.
53. Just PM. Overview of the fluoroquinolone antibiotics. Pharmacotherapy 1993;13(2 Pt 2): 4S-17S.
54. Barriere SL. Therapeutic decisions: assessing clinical fit. Pharmacotherapy 1993;13(2 Pt 2): 18S-22S.
55. Grau S. Dosificaciones especiales de los antibióticos. In: Drobnic L, ed. Temas de actualización del Curso de Formación Continuada. Barcelona: IMAS Hospital del Mar, 1995;1: 79-87.
56. Fang G, Brennen C, Wagener M et al. Use of ciprofloxacin versus use of aminoglycosydes for therapy of complicated urinary tract infections: prospective randomized clinical and pharmacokinetic study. Antimicrob Agts Chemother 1991;35: 1849-55.
57. Foxman Bobbio. Recurrent urinary tract infection: incidence and risk factors. Am J Public Health 1990; 80:331-3.
58. Stamm WE, McKevitt M, Roberts PL, et al. Natural history of recurrent urinary tract infections in women. Rev Infect Dis 1991;13: 77-84.
59. Stamey TA. Recurrent urinary tract infections in female patients: an overview of management and treatment. Rev Infect Dis 1987;9(suppl 3): 195-210.
60. Stapleton A, Latham RB, Johnson C, Stamm WE. Postcoital Antimicrobial Prophylaxis for recurrent Urinary Tract Infection. JAMA 1990;264: 703-6.
61. Patterson TF, Andriole VT. Bacteriuria in pregnancy. Infect Dis Clin North Am 1987;1: 807-22.
62. Thoumsin H, Aghayan M, Lambotte R. Single dose fosfomycin trometamol versus multiple dose nitrofurantoin in pregnant women with bacteriuria: preliminary results. Infection 1990;18(Suppl 2): S94-S97.
63. Reeves DS. Treatment of bacteriuria in pregnancy with single dose fosfomycin trometamol: A review. Infection 1992;20(Suppl 4):S313-S320.
64. Zinner S. Fosfomycin trometamol versus pipemidic acid in the treatment of bacteriuria in pregnancy. Chemotherapy 1990;36(Suppl 1): 50-52.
65. Neu HC. Fosfomycin trometamol: management of lower urinary tract infections. Chemotherapy 1990;36(Suppl 1): 53-5.
66. Briggs GG, Freeman RK, Yaffesj, eds. Drugs in pregnancy and lactation. Baltimore: Williams and Wilkins, 1994.
67. Spach DH, Stapleton AE, Stamm WE. Lack of circumcision increases the risk of urinary tract infection in young men. JAMA 1992;267: 679-81.
68. Malinverni R, Glauser MP. Comparative studies of fluoroquinolones in the treatment of urinary tract infections. Rev Infect Dis 1988;10(suppl 1): S153-S163.
69. Naber KG. Use of quinolones in urinary tract infections and prostatitis. Rev Infect Dis 1989;11(Suppl 5): S1321-S1337.
70. Chambers ST. Quinolones. N Z Med J 1995;108: 273-7.
71. Sanders WE Jr. Oral ofloxacin: a critical review of the new drug application. Clin Infect Dis 1992;14: 539-54.
72. Pfau A. Oral ofloxacin: a critical review of the new drug application. Clin Infect Dis 1993;16: 337.
73. Breitenbucher RB. UTI: Managing the most common nursing home infection. Geriatrics 1990;45: 68-75.
74. Zelger GL, Rohner P. Urinary tract infections in geriatric inpatients: Bacteriology data and resistance development. In: Zeiger GL, et al. eds. Drug treatment in the elderly. Noordwijk: ESCP, 1994: 149-53.
75. Jaff MR, Paganini EP. Meeting the challenge of geriatric UTIs. Geriatrics 1989;44: 60-6.
76. McCue J. Urinary Tract Infections in the Elderly. Pharmacotherapy 1993;13: 51S-53S.
77. Warren JW, Muncie HL Jr, Bergquist EJ, et al. Sequelae and management of urinary tract infections in the pacient requiring chronic catheterization. J Urol 1981;125: 1-8.
78. Stamm WE. Catheter-associated urinary tract infections: epidemiology, pathogenesis and prevention. Am J Med 1991;91(Suppl 3B): 65S-71S.
79. Ansari BM, Jewkes F, Davies SG. Urinary tract infection in children. Epidemiology, natural history, diagnosis and management. J Infect 1995;30: 3-6.
80. Elhanan K, Siplovich, Raz R. Gentamicin once-daily versus thrice-daily in children. J Antimicrob Chemother 1995;35: 327-32.
81. Grimwood K, Abbott MD, Fergusson BA. Single dose gentamicin treatment of urinary infections in children. N Z Med J 1988;101: 539-41.
82. Kramer SA. Summary of annual meeting of section on Pediatric Urology. Pediatrics 1990;85: 872-8.